CA3057565C - Produits et compositions - Google Patents

Produits et compositions

Info

Publication number
CA3057565C
CA3057565C CA3057565A CA3057565A CA3057565C CA 3057565 C CA3057565 C CA 3057565C CA 3057565 A CA3057565 A CA 3057565A CA 3057565 A CA3057565 A CA 3057565A CA 3057565 C CA3057565 C CA 3057565C
Authority
CA
Canada
Prior art keywords
strand
nucleic acid
modified
nucleotides
modification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3057565A
Other languages
English (en)
Other versions
CA3057565A1 (fr
Inventor
Judith HAUPTMANN
Dmitry Samarsky
Christian Frauendorf
Original Assignee
Silence Therapeutics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1707203.4A external-priority patent/GB201707203D0/en
Priority claimed from GBGB1708397.3A external-priority patent/GB201708397D0/en
Application filed by Silence Therapeutics GmbH filed Critical Silence Therapeutics GmbH
Priority claimed from PCT/EP2018/058766 external-priority patent/WO2018185241A1/fr
Publication of CA3057565A1 publication Critical patent/CA3057565A1/fr
Application granted granted Critical
Publication of CA3057565C publication Critical patent/CA3057565C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des produits et des compositions ainsi que leurs utilisations. En particulier, l'invention concerne des produits d'acide nucléique qui interfèrent avec l'expression génique ou inhibent son expression et leurs utilisations thérapeutiques, comme pour le traitement de maladies et de troubles.
CA3057565A 2017-04-05 2018-04-05 Produits et compositions Active CA3057565C (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP17165129 2017-04-05
EP17165129.2 2017-04-05
GB1707203.4 2017-05-05
GBGB1707203.4A GB201707203D0 (en) 2017-05-05 2017-05-05 Modified positions
GB1708397.3 2017-05-25
GBGB1708397.3A GB201708397D0 (en) 2017-05-25 2017-05-25 Modified positions
EP17201352.6 2017-11-13
EP17201352 2017-11-13
PCT/EP2018/058766 WO2018185241A1 (fr) 2017-04-05 2018-04-05 Produits et compositions

Publications (2)

Publication Number Publication Date
CA3057565A1 CA3057565A1 (fr) 2018-10-11
CA3057565C true CA3057565C (fr) 2025-11-25

Family

ID=

Similar Documents

Publication Publication Date Title
US12084656B2 (en) Products and compositions
US20240200071A1 (en) Nucleic acids for inhibiting expression of a target gene comprising phosphorodithioate linkages
US20210147840A1 (en) siRNAs WITH VINYLPHOSPHONATE AT THE 5' END OF THE ANTISENSE STRAND
US11987794B2 (en) Products and compositions
EP3550021A1 (fr) Produits et compositions pour l'inhibition d'expression d'un gène cible
CA3057565C (fr) Produits et compositions
EP3550022A1 (fr) Produits et compositions
HK40067116A (en) Products and compositions
HK40020523B (en) Products and compositions
HK40020523A (en) Products and compositions
HK40016476A (en) Products and compositions